BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 29761845)

  • 1. The O-methylated isoflavone, formononetin, inhibits human ovarian cancer cell proliferation by sub G0/G1 cell phase arrest through PI3K/AKT and ERK1/2 inactivation.
    Park S; Bazer FW; Lim W; Song G
    J Cell Biochem; 2018 Sep; 119(9):7377-7387. PubMed ID: 29761845
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LY294002 and metformin cooperatively enhance the inhibition of growth and the induction of apoptosis of ovarian cancer cells.
    Li C; Liu VW; Chan DW; Yao KM; Ngan HY
    Int J Gynecol Cancer; 2012 Jan; 22(1):15-22. PubMed ID: 22080879
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Formononetin promotes cell cycle arrest via downregulation of Akt/Cyclin D1/CDK4 in human prostate cancer cells.
    Li T; Zhao X; Mo Z; Huang W; Yan H; Ling Z; Ye Y
    Cell Physiol Biochem; 2014; 34(4):1351-8. PubMed ID: 25301361
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Formononetin, an isoflavone from Astragalus membranaceus inhibits proliferation and metastasis of ovarian cancer cells.
    Zhang J; Liu L; Wang J; Ren B; Zhang L; Li W
    J Ethnopharmacol; 2018 Jul; 221():91-99. PubMed ID: 29660466
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibitory Effects of Quercetin on Progression of Human Choriocarcinoma Cells Are Mediated Through PI3K/AKT and MAPK Signal Transduction Cascades.
    Lim W; Yang C; Park S; Bazer FW; Song G
    J Cell Physiol; 2017 Jun; 232(6):1428-1440. PubMed ID: 27714811
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Leptin stimulates ovarian cancer cell growth and inhibits apoptosis by increasing cyclin D1 and Mcl-1 expression via the activation of the MEK/ERK1/2 and PI3K/Akt signaling pathways.
    Chen C; Chang YC; Lan MS; Breslin M
    Int J Oncol; 2013 Mar; 42(3):1113-9. PubMed ID: 23354006
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chrysophanol Induces Apoptosis of Choriocarcinoma Through Regulation of ROS and the AKT and ERK1/2 Pathways.
    Lim W; Yang C; Bazer FW; Song G
    J Cell Physiol; 2017 Feb; 232(2):331-339. PubMed ID: 27171670
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Combined inhibition of PI3K and MEK has synergistic inhibitory effect on the proliferation of cisplatin-resistant ovarian cancer cells].
    Liu Y; Chen X; Luo Z
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2014 Jun; 30(6):592-6. PubMed ID: 24909280
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Formononetin induces cell cycle arrest of human breast cancer cells via IGF1/PI3K/Akt pathways in vitro and in vivo.
    Chen J; Zeng J; Xin M; Huang W; Chen X
    Horm Metab Res; 2011 Sep; 43(10):681-6. PubMed ID: 21932171
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Osteocalcin Induces Proliferation via Positive Activation of the PI3K/Akt, P38 MAPK Pathways and Promotes Differentiation Through Activation of the GPRC6A-ERK1/2 Pathway in C2C12 Myoblast Cells.
    Liu S; Gao F; Wen L; Ouyang M; Wang Y; Wang Q; Luo L; Jian Z
    Cell Physiol Biochem; 2017; 43(3):1100-1112. PubMed ID: 28977794
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiproliferative mechanism of a cannabinoid agonist by cell cycle arrest in human gastric cancer cells.
    Park JM; Xian XS; Choi MG; Park H; Cho YK; Lee IS; Kim SW; Chung IS
    J Cell Biochem; 2011 Apr; 112(4):1192-205. PubMed ID: 21312237
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LY294002 induces G0/G1 cell cycle arrest and apoptosis of cancer stem-like cells from human osteosarcoma via down-regulation of PI3K activity.
    Gong C; Liao H; Wang J; Lin Y; Qi J; Qin L; Tian LQ; Guo FJ
    Asian Pac J Cancer Prev; 2012; 13(7):3103-7. PubMed ID: 22994717
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Apigenin Reduces Survival of Choriocarcinoma Cells by Inducing Apoptosis via the PI3K/AKT and ERK1/2 MAPK Pathways.
    Lim W; Park S; Bazer FW; Song G
    J Cell Physiol; 2016 Dec; 231(12):2690-9. PubMed ID: 26970256
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of Autophagy Promotes Salinomycin-Induced Apoptosis via Reactive Oxygen Species-Mediated PI3K/AKT/mTOR and ERK/p38 MAPK-Dependent Signaling in Human Prostate Cancer Cells.
    Kim KY; Park KI; Kim SH; Yu SN; Park SG; Kim YW; Seo YK; Ma JY; Ahn SC
    Int J Mol Sci; 2017 May; 18(5):. PubMed ID: 28524116
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tubeimoside-1 induces oxidative stress-mediated apoptosis and G0/G1 phase arrest in human prostate carcinoma cells in vitro.
    Yang JB; Khan M; He YY; Yao M; Li YM; Gao HW; Ma TH
    Acta Pharmacol Sin; 2016 Jul; 37(7):950-62. PubMed ID: 27292614
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LY‑294002 enhances the chemosensitivity of liver cancer to oxaliplatin by blocking the PI3K/AKT/HIF‑1α pathway.
    Xu R; Zhang Y; Li A; Ma Y; Cai W; Song L; Xie Y; Zhou S; Cao W; Tang X
    Mol Med Rep; 2021 Jul; 24(1):. PubMed ID: 33982772
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Formononetin-induced apoptosis of human prostate cancer cells through ERK1/2 mitogen-activated protein kinase inactivation.
    Ye Y; Hou R; Chen J; Mo L; Zhang J; Huang Y; Mo Z
    Horm Metab Res; 2012 Apr; 44(4):263-7. PubMed ID: 22328166
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Naringenin-Induced Apoptotic Cell Death in Prostate Cancer Cells Is Mediated via the PI3K/AKT and MAPK Signaling Pathways.
    Lim W; Park S; Bazer FW; Song G
    J Cell Biochem; 2017 May; 118(5):1118-1131. PubMed ID: 27606834
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insulin-like growth factor I induces proliferation and migration of porcine trophectoderm cells through multiple cell signaling pathways, including protooncogenic protein kinase 1 and mitogen-activated protein kinase.
    Jeong W; Song G; Bazer FW; Kim J
    Mol Cell Endocrinol; 2014 Mar; 384(1-2):175-84. PubMed ID: 24508636
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PTEN sensitizes MDA-MB-468 cells to inhibition of MEK/Erk signaling for the blockade of cell proliferation.
    Jang K; Kim M; Seo HS; Shin I
    Oncol Rep; 2010 Sep; 24(3):787-93. PubMed ID: 20664988
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.